EGG-LAYING DEFECTIVE MUTANTS OF THE NEMATODE CAENORHABDITIS ELEGANS

• Published in: Genetics (Austin) Vol. 104; no. 4; pp. 619 - 647
• Main Authors: Trent, Carol, Tsung, Nancy, Horvitz, H. Robert
• Format: Journal Article
• Language: English
• Published: Bethesda, MD Genetics Soc America 01-08-1983; Genetics Society of America
• Subjects: Animals; Behavior, Animal; Biological and medical sciences; Caenorhabditis elegans; Caenorhabditis elegans - drug effects; Caenorhabditis elegans - genetics; Caenorhabditis elegans - physiology; Classical genetics, quantitative genetics, hybrids; Disorders of Sex Development; Female; Fundamental and applied biological sciences. Psychology; Genetics of eukaryotes. Biological and molecular evolution; Imipramine - pharmacology; Invertebrates; Investigations; Life cycle. Embryology. Development; Male; Mutation; Nemathelminthia. Plathelmintha; Oviposition - drug effects; Oviposition - genetics; Phenotype; Physiology. Development; Serotonin - pharmacology; Helmintha; Nemathelminthia; Mutation; Invertebrata; Nematoda; Egg laying
• ISSN: 0016-6731; 1943-2631; 1943-2631
• DOI: 10.1093/genetics/104.4.619

We have isolated 145 fertile mutants of C. elegans that are defective in egg laying and have characterized 59 of them genetically, behaviorally and pharmacologically. These 59 mutants define 40 new genes called egl. for egg-laying abnormal. Most of the other mutants are defective in previously identified genes. The egl mutants differ with respect to the severity of their egg-laying defects and the presence of behavioral or morphological pleiotropies. We have defined four distinct categories of mutants based on their responses to the pharmacological agents serotonin and imipramine, which stimulate egg laying by wild-type hermaphrodites. These drugs test the functioning of the vulva, the vulval and uterine muscles and the hermaphrodite-specific neurons (HSNs), which innervate the vulval muscles. Mutants representing 14 egl genes fail to respond to serotonin and to imipramine and are likely to be defective in the functioning of the vulva or the vulval and uterine muscles. Four mutants (representing four different genes) lay eggs in response to serotonin but not to imipramine and appear to be egg-laying defective because of defects in the HSNs; three of these four were selected specifically for these drug responses. Mutants representing seven egl genes lay eggs in response to serotonin and to imipramine. One egl mutant responds to imipramine but not to serotonin. The remaining egl mutants show variable or intermediate responses to the drugs. Two of the HSN-defective mutants, egl-1 and her-1(n695), lack HSN cell bodies and are likely to be expressing the normally male-specific program of HSN cell death. Whereas egl-1 animals appear to be defective specifically in HSN development, her-1(n695) animals exhibit multiple morphological pleiotropies, displaying partial transformation of the sexual phenotype of many cells and tissues. At least two of the egl mutants appear to be defective in the processing of environmental signals that modulate egg laying and may define new components of the neural circuitry that control egg laying.